rs9278
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004935.4(CDK5):c.*116G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.187 in 857,168 control chromosomes in the GnomAD database, including 16,668 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.15 ( 2080 hom., cov: 32)
Exomes 𝑓: 0.19 ( 14588 hom. )
Consequence
CDK5
NM_004935.4 3_prime_UTR
NM_004935.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.912
Publications
8 publications found
Genes affected
CDK5 (HGNC:1774): (cyclin dependent kinase 5) This gene encodes a proline-directed serine/threonine kinase that is a member of the cyclin-dependent kinase family of proteins. Unlike other members of the family, the protein encoded by this gene does not directly control cell cycle regulation. Instead the protein, which is predominantly expressed at high levels in mammalian postmitotic central nervous system neurons, functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. In humans, an allelic variant of the gene that results in undetectable levels of the protein has been associated with lethal autosomal recessive lissencephaly-7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]
CDK5 Gene-Disease associations (from GenCC):
- lissencephaly 7 with cerebellar hypoplasiaInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.232 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDK5 | NM_004935.4 | c.*116G>A | 3_prime_UTR_variant | Exon 12 of 12 | ENST00000485972.6 | NP_004926.1 | ||
| CDK5 | NM_001164410.3 | c.*116G>A | 3_prime_UTR_variant | Exon 11 of 11 | NP_001157882.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.152 AC: 23106AN: 152030Hom.: 2081 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
23106
AN:
152030
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.194 AC: 137027AN: 705020Hom.: 14588 Cov.: 9 AF XY: 0.197 AC XY: 70981AN XY: 360922 show subpopulations
GnomAD4 exome
AF:
AC:
137027
AN:
705020
Hom.:
Cov.:
9
AF XY:
AC XY:
70981
AN XY:
360922
show subpopulations
African (AFR)
AF:
AC:
1226
AN:
17028
American (AMR)
AF:
AC:
2172
AN:
20276
Ashkenazi Jewish (ASJ)
AF:
AC:
2614
AN:
15930
East Asian (EAS)
AF:
AC:
336
AN:
32240
South Asian (SAS)
AF:
AC:
13123
AN:
54078
European-Finnish (FIN)
AF:
AC:
5421
AN:
37240
Middle Eastern (MID)
AF:
AC:
507
AN:
2496
European-Non Finnish (NFE)
AF:
AC:
105382
AN:
491432
Other (OTH)
AF:
AC:
6246
AN:
34300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
5578
11157
16735
22314
27892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2414
4828
7242
9656
12070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.152 AC: 23113AN: 152148Hom.: 2080 Cov.: 32 AF XY: 0.146 AC XY: 10895AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
23113
AN:
152148
Hom.:
Cov.:
32
AF XY:
AC XY:
10895
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
3185
AN:
41542
American (AMR)
AF:
AC:
1910
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
580
AN:
3470
East Asian (EAS)
AF:
AC:
70
AN:
5170
South Asian (SAS)
AF:
AC:
1173
AN:
4822
European-Finnish (FIN)
AF:
AC:
1456
AN:
10614
Middle Eastern (MID)
AF:
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14215
AN:
67928
Other (OTH)
AF:
AC:
332
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1003
2006
3008
4011
5014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
483
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.